Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
Universities conducting STEM outreach: A conceptual framework

STEM and diversity

Bigger SW, Eilam E, Sadler K.
GSID: vqL_WvpMFXwJ
E Eilam, SW Bigger, K Sadler, F Barry… - Higher Education …, 2016 - Wiley Online Library

… The present paper addressed the question of high diversity among university-led STEM … approach to implementing STEM outreach as the most important factor affecting diversity. This …

Cite
Eilam, E., Bigger, S. W., Sadler, K., Barry, F., & Bielik, T. (2016). Universities conducting STEM outreach: A conceptual framework. Higher Education Quarterly, 70(4), 419-448.
Eilam, Efrat, et al. "Universities conducting STEM outreach: A conceptual framework." Higher Education Quarterly 70.4 (2016): 419-448.
Copy Download .nbib Format: MLA
Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial.

Journal of the International Society of Sports Nutrition

Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF.
PMID: 22992437
J Int Soc Sports Nutr. 2012 Sep 20;9(1):45. doi: 10.1186/1550-2783-9-45.

BACKGROUND: Probiotics are an upcoming group of nutraceuticals claiming positive effects on athlete's gut health, redox biology and immunity but there is lack of evidence to support these statements.METHODS: We conducted a randomized, double-blinded, placebo controlled trial to observe...

Cite
Lamprecht M, Bogner S, Schippinger G, et al. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr. 2012;9(1):45doi: 10.1186/1550-2783-9-45.
Lamprecht, M., Bogner, S., Schippinger, G., Steinbauer, K., Fankhauser, F., Hallstroem, S., Schuetz, B., & Greilberger, J. F. (2012). Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. Journal of the International Society of Sports Nutrition, 9(1), 45. https://doi.org/10.1186/1550-2783-9-45
Lamprecht, Manfred, et al. "Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial." Journal of the International Society of Sports Nutrition vol. 9,1 (2012): 45. doi: https://doi.org/10.1186/1550-2783-9-45
Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr. 2012 Sep 20;9(1):45. doi: 10.1186/1550-2783-9-45. PMID: 22992437; PMCID: PMC3465223.
Copy Download .nbib Format: NLM
Driving perpendicular heat flow: (p×n)-type transverse thermoelectrics for microscale and cryogenic Peltier cooling.

Physical review letters

Zhou C, Birner S, Tang Y, Heinselman K, Grayson M.
PMID: 23767747
Phys Rev Lett. 2013 May 31;110(22):227701. doi: 10.1103/PhysRevLett.110.227701. Epub 2013 May 31.

Whereas thermoelectric performance is normally limited by the figure of merit ZT, transverse thermoelectrics can achieve arbitrarily large temperature differences in a single leg even with inferior ZT by being geometrically tapered. We introduce a band-engineered transverse thermoelectric with...

Cite
Zhou C, Birner S, Tang Y, et al. Driving perpendicular heat flow: (p×n)-type transverse thermoelectrics for microscale and cryogenic Peltier cooling. Phys Rev Lett. 2013;110(22):227701doi: 10.1103/PhysRevLett.110.227701.
Zhou, C., Birner, S., Tang, Y., Heinselman, K., & Grayson, M. (2013). Driving perpendicular heat flow: (p×n)-type transverse thermoelectrics for microscale and cryogenic Peltier cooling. Physical review letters, 110(22), 227701. https://doi.org/10.1103/PhysRevLett.110.227701
Zhou, Chuanle, et al. "Driving perpendicular heat flow: (p×n)-type transverse thermoelectrics for microscale and cryogenic Peltier cooling." Physical review letters vol. 110,22 (2013): 227701. doi: https://doi.org/10.1103/PhysRevLett.110.227701
Zhou C, Birner S, Tang Y, Heinselman K, Grayson M. Driving perpendicular heat flow: (p×n)-type transverse thermoelectrics for microscale and cryogenic Peltier cooling. Phys Rev Lett. 2013 May 31;110(22):227701. doi: 10.1103/PhysRevLett.110.227701. Epub 2013 May 31. PMID: 23767747.
Copy Download .nbib Format: NLM
Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas.

Oncoimmunology

Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner DD, Sampson J, Mitchell DA.
PMID: 25949916
Oncoimmunology. 2015 Jan 22;4(3):e994374. doi: 10.4161/2162402X.2014.994374. eCollection 2015 Mar.

Adoptive cellular therapy (ACT) after lymphodepletive conditioning can induce dramatic clinical responses, but this approach has been largely limited to melanoma due to a lack of reliable methods for expanding tumor-specific lymphocytes from the majority of other solid cancers....

Cite
Flores C, Pham C, Snyder D, et al. Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. Oncoimmunology. 2015;4(3):e994374doi: 10.4161/2162402X.2014.994374.
Flores, C., Pham, C., Snyder, D., Yang, S., Sanchez-Perez, L., Sayour, E., Cui, X., Kemeny, H., Friedman, H., Bigner, D. D., Sampson, J., & Mitchell, D. A. (2015). Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. Oncoimmunology, 4(3), e994374. https://doi.org/10.4161/2162402X.2014.994374
Flores, Catherine, et al. "Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas." Oncoimmunology vol. 4,3 (2015): e994374. doi: https://doi.org/10.4161/2162402X.2014.994374
Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner DD, Sampson J, Mitchell DA. Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. Oncoimmunology. 2015 Jan 22;4(3):e994374. doi: 10.4161/2162402X.2014.994374. eCollection 2015 Mar. PMID: 25949916; PMCID: PMC4404923.
Copy Download .nbib Format: NLM
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic.

Drugs of the future

Gedeon PC, Choi BD, Sampson JH, Bigner DD.
PMID: 25663738
Drugs Future. 2013 Mar;38(3):147-155. doi: 10.1358/dof.2013.038.03.1933992.

Glioblastoma, the most common primary malignant brain tumor, is among the most difficult cancers to treat. Despite the aggressive standard of care, including surgical removal followed by radiotherapy with concomitant and adjuvant chemotherapy, the often sudden onset, diffuse infiltrating...

Cite
Gedeon PC, Choi BD, Sampson JH, et al. Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic. Drugs Future. 2013;38(3):147-155doi: 10.1358/dof.2013.038.03.1933992.
Gedeon, P. C., Choi, B. D., Sampson, J. H., & Bigner, D. D. (2013). Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic. Drugs of the future, 38(3), 147-155. https://doi.org/10.1358/dof.2013.038.03.1933992
Gedeon, Patrick C, et al. "Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic." Drugs of the future vol. 38,3 (2013): 147-155. doi: https://doi.org/10.1358/dof.2013.038.03.1933992
Gedeon PC, Choi BD, Sampson JH, Bigner DD. Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic. Drugs Future. 2013 Mar;38(3):147-155. doi: 10.1358/dof.2013.038.03.1933992. PMID: 25663738; PMCID: PMC4317793.
Copy Download .nbib Format: NLM
Use of Modeling Techniques to Aid in Antibiotic Selection.

Current infectious disease reports

Firsov AA, Zinner SH.
PMID: 11177729
Curr Infect Dis Rep. 2001 Feb;3(1):35-43. doi: 10.1007/s11908-001-0057-9.

Over the past decade, the use of modeling techniques in the development of novel antibiotics has been primarily associated with in vitro dynamic models. These models allow comparisons among different antibiotics by simulating human pharmacokinetics. Although dynamic models have...

Cite
Firsov AA, Zinner SH. Use of Modeling Techniques to Aid in Antibiotic Selection. Curr Infect Dis Rep. 2001;3(1):35-43doi: 10.1007/s11908-001-0057-9.
Firsov, A. A., & Zinner, S. H. (2001). Use of Modeling Techniques to Aid in Antibiotic Selection. Current infectious disease reports, 3(1), 35-43. https://doi.org/10.1007/s11908-001-0057-9
Firsov, Alexander A., and Zinner, Stephen H.. "Use of Modeling Techniques to Aid in Antibiotic Selection." Current infectious disease reports vol. 3,1 (2001): 35-43. doi: https://doi.org/10.1007/s11908-001-0057-9
Firsov AA, Zinner SH. Use of Modeling Techniques to Aid in Antibiotic Selection. Curr Infect Dis Rep. 2001 Feb;3(1):35-43. doi: 10.1007/s11908-001-0057-9. PMID: 11177729.
Copy Download .nbib Format: NLM
Becoming politically savvy. A past NSNA president highlights her inspired path to leadership.

Imprint

Brigner S.
PMID: 11765425
Imprint. 2001 Nov-Dec;48(4):59-60.

No abstract available.

Cite
Brigner S. Becoming politically savvy. A past NSNA president highlights her inspired path to leadership. Imprint. 2001;48(4):59-60
Brigner, S. (2001). Becoming politically savvy. A past NSNA president highlights her inspired path to leadership. Imprint, 48(4), 59-60.
Brigner, S. "Becoming politically savvy. A past NSNA president highlights her inspired path to leadership." Imprint vol. 48,4 (2001): 59-60.
Brigner S. Becoming politically savvy. A past NSNA president highlights her inspired path to leadership. Imprint. 2001 Nov-Dec;48(4):59-60. PMID: 11765425.
Copy Download .nbib Format: NLM
Limited-incision carpal tunnel release.

Techniques in hand & upper extremity surgery

Bowers WH, Berner SH.
PMID: 16609524
Tech Hand Up Extrem Surg. 1997 Mar;1(1):15-20. doi: 10.1097/00130911-199703000-00004.

No abstract available.

Cite
Bowers WH, Berner SH. Limited-incision carpal tunnel release. Tech Hand Up Extrem Surg. 1997;1(1):15-20doi: 10.1097/00130911-199703000-00004.
Bowers, W. H., & Berner, S. H. (1997). Limited-incision carpal tunnel release. Techniques in hand & upper extremity surgery, 1(1), 15-20. https://doi.org/10.1097/00130911-199703000-00004
Bowers, W H, and Berner, S H. "Limited-incision carpal tunnel release." Techniques in hand & upper extremity surgery vol. 1,1 (1997): 15-20. doi: https://doi.org/10.1097/00130911-199703000-00004
Bowers WH, Berner SH. Limited-incision carpal tunnel release. Tech Hand Up Extrem Surg. 1997 Mar;1(1):15-20. doi: 10.1097/00130911-199703000-00004. PMID: 16609524.
Copy Download .nbib Format: NLM
Sodium lactate and storage temperature effects on shelf life of vacuum packaged beef top rounds.

Meat science

Maca JV, Miller RK, Bigner ME, Lucia LM, Acuff GR.
PMID: 22062929
Meat Sci. 1999 Sep;53(1):23-9. doi: 10.1016/s0309-1740(99)00032-7.

Cooked, vacuum-packaged beef top rounds containing up to 4% sodium lactate (NaL) in the final product were stored at 0, 4, 10 or 16°C for 1, 7, 14 or 21 days. Aerobic plate counts (APCs) were lower for roasts...

Cite
Maca JV, Miller RK, Bigner ME, et al. Sodium lactate and storage temperature effects on shelf life of vacuum packaged beef top rounds. Meat Sci. 1999;53(1):23-9doi: 10.1016/s0309-1740(99)00032-7.
Maca, J. V., Miller, R. K., Bigner, M. E., Lucia, L. M., & Acuff, G. R. (1999). Sodium lactate and storage temperature effects on shelf life of vacuum packaged beef top rounds. Meat science, 53(1), 23-9. https://doi.org/10.1016/s0309-1740(99)00032-7
Maca, J V, et al. "Sodium lactate and storage temperature effects on shelf life of vacuum packaged beef top rounds." Meat science vol. 53,1 (1999): 23-9. doi: https://doi.org/10.1016/s0309-1740(99)00032-7
Maca JV, Miller RK, Bigner ME, Lucia LM, Acuff GR. Sodium lactate and storage temperature effects on shelf life of vacuum packaged beef top rounds. Meat Sci. 1999 Sep;53(1):23-9. doi: 10.1016/s0309-1740(99)00032-7. PMID: 22062929.
Copy Download .nbib Format: NLM
Pharmacy compounding at the University of Connecticut: secundem artem et scientia.

International journal of pharmaceutical compounding

Scagliarini M, Bogner RH.
PMID: 23969708
Int J Pharm Compd. 2008 May-Jun;12(3):208-12.

The curriculum of the University of Connecticut School of Pharmacy continues to evolve just as the practice of pharmacy evolves. This is especially true in the practice of compounding, which has re-emerged as a respected art and science. The...

Cite
Scagliarini M, Bogner RH. Pharmacy compounding at the University of Connecticut: secundem artem et scientia. Int J Pharm Compd. 2008;12(3):208-12
Scagliarini, M., & Bogner, R. H. (2008). Pharmacy compounding at the University of Connecticut: secundem artem et scientia. International journal of pharmaceutical compounding, 12(3), 208-12.
Scagliarini, Meghan, and Bogner, Robin H. "Pharmacy compounding at the University of Connecticut: secundem artem et scientia." International journal of pharmaceutical compounding vol. 12,3 (2008): 208-12.
Scagliarini M, Bogner RH. Pharmacy compounding at the University of Connecticut: secundem artem et scientia. Int J Pharm Compd. 2008 May-Jun;12(3):208-12. PMID: 23969708.
Copy Download .nbib Format: NLM
Investigating Manuka Honey Antibacterial Properties When Incorporated into Cryogel, Hydrogel, and Electrospun Tissue Engineering Scaffolds.

Gels (Basel, Switzerland)

Hixon KR, Bogner SJ, Ronning-Arnesen G, Janowiak BE, Sell SA.
PMID: 31003516
Gels. 2019 Apr 18;5(2). doi: 10.3390/gels5020021.

Honey is well-known for its wound healing capability and Manuka honey (MH) contains a unique Manuka factor, providing an additional antibacterial agent. Previously, there has not been a practical way to apply MH to a wound site, which renders...

Cite
Hixon KR, Bogner SJ, Ronning-Arnesen G, et al. Investigating Manuka Honey Antibacterial Properties When Incorporated into Cryogel, Hydrogel, and Electrospun Tissue Engineering Scaffolds. Gels. 2019;5(2)doi: 10.3390/gels5020021.
Hixon, K. R., Bogner, S. J., Ronning-Arnesen, G., Janowiak, B. E., & Sell, S. A. (2019). Investigating Manuka Honey Antibacterial Properties When Incorporated into Cryogel, Hydrogel, and Electrospun Tissue Engineering Scaffolds. Gels (Basel, Switzerland), 5(2), . https://doi.org/10.3390/gels5020021
Hixon, Katherine R, et al. "Investigating Manuka Honey Antibacterial Properties When Incorporated into Cryogel, Hydrogel, and Electrospun Tissue Engineering Scaffolds." Gels (Basel, Switzerland) vol. 5,2 (2019). doi: https://doi.org/10.3390/gels5020021
Hixon KR, Bogner SJ, Ronning-Arnesen G, Janowiak BE, Sell SA. Investigating Manuka Honey Antibacterial Properties When Incorporated into Cryogel, Hydrogel, and Electrospun Tissue Engineering Scaffolds. Gels. 2019 Apr 18;5(2). doi: 10.3390/gels5020021. PMID: 31003516; PMCID: PMC6631429.
Copy Download .nbib Format: NLM
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.

Frontiers in neurology

Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, Neuwirth C, Günther R, Benatar M, Kuzma-Kozakiewicz M, Bidner H, Blankenstein C, Frontini R, Ludolph A, Koch JC.
PMID: 30972018
Front Neurol. 2019 Mar 27;10:293. doi: 10.3389/fneur.2019.00293. eCollection 2019.

No abstract available.

Cite
Lingor P, Weber M, Camu W, et al. ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis. Front Neurol. 2019;10:293doi: 10.3389/fneur.2019.00293.
Lingor, P., Weber, M., Camu, W., Friede, T., Hilgers, R., Leha, A., Neuwirth, C., Günther, R., Benatar, M., Kuzma-Kozakiewicz, M., Bidner, H., Blankenstein, C., Frontini, R., Ludolph, A., Koch, J. C. (2019). ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis. Frontiers in neurology, 10293. https://doi.org/10.3389/fneur.2019.00293
Lingor, Paul, et al. "ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis." Frontiers in neurology vol. 10 (2019): 293. doi: https://doi.org/10.3389/fneur.2019.00293
Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, Neuwirth C, Günther R, Benatar M, Kuzma-Kozakiewicz M, Bidner H, Blankenstein C, Frontini R, Ludolph A, Koch JC. ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis. Front Neurol. 2019 Mar 27;10:293. doi: 10.3389/fneur.2019.00293. eCollection 2019. PMID: 30972018; PMCID: PMC6446974.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries